(MedPage Today) -- The FDA approved linerixibat (Lynavoy) as the first drug indicated for cholestatic pruritus stemming from primary biliary cholangitis (PBC), drugmaker GSK announced on Thursday. PBC is a rare but serious autoimmune disease where...
Source
MedPage Today
Opens original article in a new tab
Hundreds of individualized treatments for rare diseases could become available over the next decade — but only if government regulators handle the new therapeutics properly. At least that’s how Robert…
A U.S. district judge said he will vacate a declaration by Kennedy that asserted gender-affirming care for young trans people does not meet medical standards of care.
If the U.S. wants to hold on to its title as the world's top biotech innovator, it might want to take a page out of China's book, a pioneer in…
A group of autism scientists kicked off efforts Thursday to influence Congress, and the research agendas of private organizations.